Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1144 to 1193 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cpg binding protein (protein containing phd finger and cxxc domain 1). [source:swissprot;acc:q9p0u4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08858\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5893.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6416.07\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activator of basal transcription 1; tata-binding protein-binding protein; basal transcriptional activator. [source:refseq;acc:nm\_013375]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytokine-like nuclear factor n-pac. [source:refseq;acc:nm\_032569]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hect type e3 ubiquitin ligase. [source:refseq;acc:nm\_015052]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 3 (esg3). [source:swissprot;acc:q04726]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6280.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6837.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mstp028 protein. [source:refseq;acc:nm\_031954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5838.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1151\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5322.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5793.15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08838\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1152\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-centractin (actin-related protein 1b) (arp1b). [source:swissprot;acc:p42025]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily b member 1 (integrase interactor 1 protein) (hsnf5) (baf47). [source:swissprot;acc:q12824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08828\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor necrosis factor, alpha-induced protein 1, endothelial (b12 protein). [source:swissprot;acc:q13829]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08821\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 4. [source:swissprot;acc:q04727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6270.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6823.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase delta-interacting protein 1; tnfaip1-like. [source:refseq;acc:nm\_178863]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08819\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine hydroxymethyltransferase, cytosolic (ec 2.1.2.1) (serine methylase) (glycine hydroxymethyltransferase) (shmt). [source:swissprot;acc:p34896]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5418.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5895.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08801\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5489.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5972.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08797\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5538.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6025.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08787\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetyltransferase 5 (ec 2.3.1.-). [source:swissprot;acc:q9y6d2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5315.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5782.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nemo-like kinase; likely ortholog of mouse nemo like kinase. [source:refseq;acc:nm\_016231]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5832.13\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6343.59\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0877\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elks protein. [source:refseq;acc:nm\_015064]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sodium/iodide cotransporter (na(+)/i(-) cotransporter) (sodium-iodide symporter) (na+/i-symporter). [source:swissprot;acc:q92911]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6600.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7178.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kidney and liver proline oxidase 1. [source:refseq;acc:nm\_021232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6604.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7183.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08761\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 5 (iodide transporter), member 8; apical iodide transporter. [source:refseq;acc:nm\_145913]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6606.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7185.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sodium-dependent multivitamin transporter (na(+)-dependent multivitamin transporter). [source:swissprot;acc:q9y289]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6607.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7186.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08759\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic checkpoint protein bub3. [source:swissprot;acc:o43684]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5470.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5949.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08757\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 207. [source:swissprot;acc:o43670]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3a. [source:swissprot;acc:p55854]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5826.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6335.98\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08747\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5826.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6335.93\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acrc protein; putative nuclear protein. [source:refseq;acc:nm\_052957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5826.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6335.95\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chaperone-activity of bc1 complex-like, mitochondrial precursor (chaperone-abc1-like). [source:swissprot;acc:q8ni60]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5799.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6305.95\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08735\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cda11 protein. [source:refseq;acc:nm\_032026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6387.23\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 2; putative ubiquinone biosynthesis protein aarf. [source:refseq;acc:nm\_052853]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5799.35\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6305.95\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 4. [source:refseq;acc:nm\_024876]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 1. [source:refseq;acc:nm\_020421]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pepsin a precursor (ec 3.4.23.1). [source:swissprot;acc:p00790]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
farnesyl pyrophosphate synthetase (fpp synthetase) (fps) (farnesyl diphosphate synthetase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10)]. [source:swissprot;acc:p14324]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 1; glvr-1; pit-1; gibbon ape leukemia virus receptor 1. [source:refseq;acc:nm\_005415]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipocalin-interacting membrane receptor. [source:refseq;acc:nm\_018113]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli1 (glioma-associated oncogene) (oncogene gli). [source:swissprot;acc:p08151]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of fused. [source:refseq;acc:nm\_016169]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli3. [source:swissprot;acc:p10071]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
limb region 1 protein; limb region 1. [source:refseq;acc:nm\_022458]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein gli2 (tax helper protein). [source:swissprot;acc:p10070]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2a (mad2-like 1) (hsmad2). [source:swissprot;acc:q13257]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6599.84\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7174.29\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08704\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable cation-transporting atpase 1 (ec 3.6.1.-). [source:swissprot;acc:q9nq11]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata box binding protein (transcription initiation factor tfiid) (tata-box factor) (tata sequence-binding protein) (tbp). [source:swissprot;acc:p20226]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 3 subunit (eif-3) (fragment). [source:swissprot;acc:o75153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5464.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5940.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08697\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/